These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6915349)

  • 1. [Treatment of myeloma disease].
    Verevkin IN
    Med Sestra; 1981 Nov; 40(11):5-7. PubMed ID: 6915349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renal insufficiency and myeloma: therapeutic success in relation to reduction of tumor mass].
    Bondía Román A; San Miguel J; Guervos CS; Batlle F; Tabernero Romo JM; López-Borrasca A
    Rev Clin Esp; 1982 Feb; 164(3):191-2. PubMed ID: 7089337
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple complications in multiple myeloma.
    Basi S; Schulman G; Fogo AB
    Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience with the treatment of multiple myeloma and its complications].
    Abdulkadyrov KM; Ushakova EA
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):35-40. PubMed ID: 523449
    [No Abstract]   [Full Text] [Related]  

  • 5. The management of multiple myeloma.
    Luikart S; Weininger RB
    Conn Med; 1980 Sep; 44(9):553-6. PubMed ID: 7408479
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
    Bergner R; Hoffmann M; Uppenkamp M
    Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonsecretory myeloma. A case report.
    Moehring HD
    Clin Orthop Relat Res; 1982; (171):196-201. PubMed ID: 7140070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient rehabilitation in persons with multiple myeloma-associated fractures: an analysis of 8 consecutive inpatient admissions.
    Cheng DS; O'Dell MW
    PM R; 2011 Jan; 3(1):78-84. PubMed ID: 21257138
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosing chemotherapy agents in hemodialysis--a focus on multiple myeloma.
    Runnels R; Cameron K; Ng P; Battistella M
    CANNT J; 2014; 24(1):21-5; quiz 26-7. PubMed ID: 24783769
    [No Abstract]   [Full Text] [Related]  

  • 10. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in multiple myeloma].
    Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A
    Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term pamidronate in multiple myeloma.
    Seymour JF
    J Clin Oncol; 1998 Jul; 16(7):2572-3. PubMed ID: 9667282
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressive plasma cell myeloma. A terminal phase.
    Suchman AL; Coleman M; Mouradian JA; Wolf DJ; Saletan S
    Arch Intern Med; 1981 Sep; 141(10):1315-20. PubMed ID: 7271406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal insufficiency in myelomatosis. Prognostic factors and survival].
    Gregersen H; Ibsen JS; Nielsen M
    Ugeskr Laeger; 1997 May; 159(22):3387-92. PubMed ID: 9199025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma.
    Malpas JS
    Br J Hosp Med; 1977 Nov; 18(5):478, 481-4, 487. PubMed ID: 597659
    [No Abstract]   [Full Text] [Related]  

  • 17. Humbling snapshots.
    Kellerman PS
    Am J Kidney Dis; 2011 Jun; 57(6):A21-3. PubMed ID: 21601122
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
    Grasko JM; Herrmann RP; Vasikaran SD
    J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of multiple myeloma (generalized plasmacytoma)].
    Andreeva NE; Antipova LG
    Probl Gematol Pereliv Krovi; 1975 Mar; 20(3):51-7. PubMed ID: 768974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.